D
Description
DEVA Holding, founded in 1958 and ranked 3rd in unit sales (5.3%) in Turkey's pharma market, operates three EU GMP- and USFDA-approved facilities in Çerkezköy and Kartepe with 620M unit annual capacity and 1,404 registered products in 82 countries. Turkey's leading pharma company in R&D spending (Turkishtime 2024), with 500+ researchers and 3,000 total staff. Covers 10 therapeutic areas.